Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Vox Royalty Corp (VOX:CN) (VOXCF) PT Raised to Cdn$4.25 at Cantor Fitzgerald
-
Emergent BioSolutions (EBS) PT Lowered to $110 at Cantor Fitzgerald
-
Innoviz Technologies (INVZ) and Collective Growth Corporation (CGRO) Announce Closing of Business Combination
-
Innoviz Technologies and Collective Growth Corporation Announce Closing of Business Combination
-
Form 4 NEWMARK GROUP, INC. For: Mar 31 Filed by: CANTOR FITZGERALD, L. P.
-
Form 4 BGC Partners, Inc. For: Mar 31 Filed by: CANTOR FITZGERALD, L. P.
-
Form 8-K Cantor Fitzgerald Income For: Mar 26
-
Penny Stocks To Buy Now According To 3 Top Wall Street Analysts
-
Cantor Fitzgerald Income Trust, Inc. Extends Lease Term on Seven Walgreens Locations
-
Phreesia Inc. (PHR) PT Raised to $60 at Cantor Fitzgerald
-
Pre-Open Stock Movers 03/31: (SURF) (CHWY) (CASI) Higher; (DCTH) (RMO) (CLSN) Lower (more...)
-
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2020 Results
-
Procaps Group is Going Public via Merger with Union Acquisition Corp II (LATN)
-
Procaps Group, a Leading Global Pharmaceutical Technology and Healthcare Company Based in Latin America, Going Public via Merger with Union Acquisition Corp II
-
ProQR (PRQR) Prices 13.846M Share Common Offering at $6.50/Sh
-
Humanigen Inc. (HGEN) Prices 5M Share Common Offering at $18.50/Sh
-
ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares
-
ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares
-
Humanigen Announces Pricing of Public Offering of Five Million Shares of Common Stock
-
After-Hours Stock Movers 03/30: (SURF) (CASI) (CHWY) Higher; (NMTR) (OSMT) (BB) Lower (more...)
-
Form 424B3 Cantor Fitzgerald Income
-
ProQR (PRQR) Announces Proposed Underwritten Public Offering of Ordinary Shares
-
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
-
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
-
Cantor Fitzgerald Starts Lineage Cell Therapeutics Inc. (LCTX) at Overweight
-
4 Penny Stocks On Robinhood To Watch In April 2021
-
Pre-Open Stock Movers 03/30: (MBRX) (ABCL) (SEEL) Higher; (WVE) (BFLY) (CLDX) Lower (more...)
-
COVA Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants Commencing March 30, 2021
-
After-Hours Stock Movers 03/29: (BIOC) (SEAC) (NOVN) Higher; (WVE) (BFLY) (CLDX) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts PAVmed (PAVM) at Overweight
-
Humanigen Inc. (HGEN) Announces Proposed Public Offering of 5M Shares of Common Stock
-
Humanigen Announces Proposed Public Offering of Five Million Shares of Common Stock
-
Cantor Fitzgerald Starts Aytu Biosciences (AYTU) at Overweight
-
Ocugen Inc. to Participate in a Cantor Fitzgerald Fireside Chat to Discuss COVAXIN COVID-19 Vaccine Development
-
Eloro Resources Provides Update on Iska Iska Silver-Tin Polymetallic Project, Potosi Department, Southern Bolivia
-
Atlas Crest Investment Corp. II Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 29, 2021
-
Atlas Crest Investment Corp. II Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 29, 2021
-
Eloro Resources Closes C$25 Million Bought Deal Financing
-
Companies with NDRs 3/26
-
Form 10-K Cantor Fitzgerald Income For: Dec 31
-
Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Cresco Labs Inc. (CRLBF) PT Raised to $22.50 at Cantor Fitzgerald
-
Update: CFN Media & Intro-act Collaborate to Launch Unified Digital Outreach Program for the Cannabis Industry
-
ProQR Therapeutics N.V. (PRQR) PT Raised to $33 at Cantor Fitzgerald
-
Prothena Corp. (PRTA) Prices 3.5M Offering of Ordinary Shares at $20.75/sh
-
Prothena Announces Pricing of Public Offering of 3,500,000 Ordinary Shares
-
Prothena Announces Pricing of Public Offering of 3,500,000 Ordinary Shares
-
Prothena Corp. (PRTA) Announces Proposed Offering of Ordinary Shares

